Global Gastrointestinal Therapeutics Market Insights and Forecast to 2031

Report ID: 1380344 | Published Date: Dec 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Parenteral
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 IBD
        1.3.3 Irritable Bowel Syndrome (IBS)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastrointestinal Therapeutics Market Perspective (2017-2028)
    2.2 Gastrointestinal Therapeutics Growth Trends by Region
        2.2.1 Gastrointestinal Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Gastrointestinal Therapeutics Market Dynamics
        2.3.1 Gastrointestinal Therapeutics Industry Trends
        2.3.2 Gastrointestinal Therapeutics Market Drivers
        2.3.3 Gastrointestinal Therapeutics Market Challenges
        2.3.4 Gastrointestinal Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Therapeutics Players by Revenue
        3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
    3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
        3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2021
    3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics Breakdown Data by Type
    4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Therapeutics Breakdown Data by Application
    5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Therapeutics Market Size (2017-2028)
    6.2 North America Gastrointestinal Therapeutics Market Size by Type
        6.2.1 North America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
    6.3 North America Gastrointestinal Therapeutics Market Size by Application
        6.3.1 North America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
    6.4 North America Gastrointestinal Therapeutics Market Size by Country
        6.4.1 North America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Therapeutics Market Size (2017-2028)
    7.2 Europe Gastrointestinal Therapeutics Market Size by Type
        7.2.1 Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Gastrointestinal Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Gastrointestinal Therapeutics Market Size by Application
        7.3.1 Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Gastrointestinal Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Gastrointestinal Therapeutics Market Size by Country
        7.4.1 Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gastrointestinal Therapeutics Market Size (2017-2028)
    9.2 Latin America Gastrointestinal Therapeutics Market Size by Type
        9.2.1 Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Gastrointestinal Therapeutics Market Size by Application
        9.3.1 Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Gastrointestinal Therapeutics Market Size by Country
        9.4.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
        11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Gastrointestinal Therapeutics Introduction
        11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.2.5 Allergan Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
        11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Takeda
        11.4.1 Takeda Company Details
        11.4.2 Takeda Business Overview
        11.4.3 Takeda Gastrointestinal Therapeutics Introduction
        11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.4.5 Takeda Recent Developments
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Gastrointestinal Therapeutics Introduction
        11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.5.5 Novartis Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
        11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.6.5 Pfizer Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Gastrointestinal Therapeutics Introduction
        11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 F. Hoffmann-La Roche
        11.8.1 F. Hoffmann-La Roche Company Details
        11.8.2 F. Hoffmann-La Roche Business Overview
        11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
        11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.8.5 F. Hoffmann-La Roche Recent Developments
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Details
        11.9.2 Eli Lilly Business Overview
        11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
        11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.9.5 Eli Lilly Recent Developments
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
        11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.10.5 AstraZeneca Recent Developments
    11.11 Procter & Gamble
        11.11.1 Procter & Gamble Company Details
        11.11.2 Procter & Gamble Business Overview
        11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
        11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.11.5 Procter & Gamble Recent Developments
    11.12 Tillotts Pharma
        11.12.1 Tillotts Pharma Company Details
        11.12.2 Tillotts Pharma Business Overview
        11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
        11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.12.5 Tillotts Pharma Recent Developments
    11.13 Takeda
        11.13.1 Takeda Company Details
        11.13.2 Takeda Business Overview
        11.13.3 Takeda Gastrointestinal Therapeutics Introduction
        11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.13.5 Takeda Recent Developments
    11.14 GlaxoSmithKline
        11.14.1 GlaxoSmithKline Company Details
        11.14.2 GlaxoSmithKline Business Overview
        11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
        11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.14.5 GlaxoSmithKline Recent Developments
    11.15 Amgen
        11.15.1 Amgen Company Details
        11.15.2 Amgen Business Overview
        11.15.3 Amgen Gastrointestinal Therapeutics Introduction
        11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022)
        11.15.5 Amgen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral
    Table 3. Key Players of Parenteral
    Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Gastrointestinal Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2023-2028)
    Table 10. Gastrointestinal Therapeutics Market Trends
    Table 11. Gastrointestinal Therapeutics Market Drivers
    Table 12. Gastrointestinal Therapeutics Market Challenges
    Table 13. Gastrointestinal Therapeutics Market Restraints
    Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Gastrointestinal Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
    Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service
    Table 21. Date of Enter into Gastrointestinal Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Gastrointestinal Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Gastrointestinal Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Gastrointestinal Therapeutics Product
    Table 64. AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. AbbVie Recent Developments
    Table 66. Allergan Company Details
    Table 67. Allergan Business Overview
    Table 68. Allergan Gastrointestinal Therapeutics Product
    Table 69. Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Allergan Recent Developments
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Gastrointestinal Therapeutics Product
    Table 74. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Johnson & Johnson Recent Developments
    Table 76. Takeda Company Details
    Table 77. Takeda Business Overview
    Table 78. Takeda Gastrointestinal Therapeutics Product
    Table 79. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Takeda Recent Developments
    Table 81. Novartis Company Details
    Table 82. Novartis Business Overview
    Table 83. Novartis Gastrointestinal Therapeutics Product
    Table 84. Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Novartis Recent Developments
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Gastrointestinal Therapeutics Product
    Table 89. Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Pfizer Recent Developments
    Table 91. Merck Company Details
    Table 92. Merck Business Overview
    Table 93. Merck Gastrointestinal Therapeutics Product
    Table 94. Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Merck Recent Developments
    Table 96. F. Hoffmann-La Roche Company Details
    Table 97. F. Hoffmann-La Roche Business Overview
    Table 98. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product
    Table 99. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. F. Hoffmann-La Roche Recent Developments
    Table 101. Eli Lilly Company Details
    Table 102. Eli Lilly Business Overview
    Table 103. Eli Lilly Gastrointestinal Therapeutics Product
    Table 104. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Eli Lilly Recent Developments
    Table 106. AstraZeneca Company Details
    Table 107. AstraZeneca Business Overview
    Table 108. AstraZeneca Gastrointestinal Therapeutics Product
    Table 109. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. AstraZeneca Recent Developments
    Table 111. Procter & Gamble Company Details
    Table 112. Procter & Gamble Business Overview
    Table 113. Procter & Gamble Gastrointestinal Therapeutics Product
    Table 114. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. Procter & Gamble Recent Developments
    Table 116. Tillotts Pharma Company Details
    Table 117. Tillotts Pharma Business Overview
    Table 118. Tillotts Pharma Gastrointestinal Therapeutics Product
    Table 119. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. Tillotts Pharma Recent Developments
    Table 121. Takeda Company Details
    Table 122. Takeda Business Overview
    Table 123. Takeda Gastrointestinal Therapeutics Product
    Table 124. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 125. Takeda Recent Developments
    Table 126. GlaxoSmithKline Company Details
    Table 127. GlaxoSmithKline Business Overview
    Table 128. GlaxoSmithKline Gastrointestinal Therapeutics Product
    Table 129. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 130. GlaxoSmithKline Recent Developments
    Table 131. Amgen Company Details
    Table 132. Amgen Business Overview
    Table 133. Amgen Gastrointestinal Therapeutics Product
    Table 134. Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
    Table 135. Amgen Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Oral Features
    Figure 3. Parenteral Features
    Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. IBD Case Studies
    Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
    Figure 7. Gastrointestinal Therapeutics Report Years Considered
    Figure 8. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Gastrointestinal Therapeutics Market Share by Region: 2021 VS 2028
    Figure 11. Global Gastrointestinal Therapeutics Market Share by Players in 2021
    Figure 12. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2021
    Figure 14. North America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 16. North America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 17. North America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
    Figure 18. United States Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 22. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 23. Europe Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
    Figure 24. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific Gastrointestinal Therapeutics Market Size Share by Region (2017-2028)
    Figure 34. China Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
    Figure 44. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
    Figure 50. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 54. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 55. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 56. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 61. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 62. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 63. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 64. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 65. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 66. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 67. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Frequently Asked Questions
Gastrointestinal Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gastroscopes

Gastroscopes market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More